Billy Flynn would have been devastated. For once, the ol’ razzle-dazzle just didn’t work. GlaxoSmithKline, the UK’s largest drug conglomerate, which has grown fatter and fatter acquiring pharmaceutical small fry
Billy Flynn would have been devastated. For once, the ol’ razzle-dazzle just didn’t work. GlaxoSmithKline, the UK’s largest drug conglomerate, which has grown fatter and fatter acquiring pharmaceutical small fry